
Acurx Pharmaceuticals Inc
NASDAQ:ACXP

Fundamental Analysis


Revenue & Expenses Breakdown
Acurx Pharmaceuticals Inc
Balance Sheet Decomposition
Acurx Pharmaceuticals Inc
Current Assets | 4.8m |
Cash & Short-Term Investments | 4.6m |
Other Current Assets | 161.6k |
Free Cash Flow Analysis
Acurx Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Acurx Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-11.9m
USD
|
Operating Income
|
-11.9m
USD
|
Other Expenses
|
0
USD
|
Net Income
|
-11.9m
USD
|
ACXP Profitability Score
Profitability Due Diligence
Acurx Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Acurx Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
ACXP Solvency Score
Solvency Due Diligence
Acurx Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Acurx Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ACXP Price Targets Summary
Acurx Pharmaceuticals Inc
Dividends
Current shareholder yield for ACXP is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?